$19.52
2.63% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
IL0011595993
Symbol
INMD

Inmode Stock price

$19.52
+1.97 11.23% 1M
+1.04 5.63% 6M
-2.72 12.23% YTD
-3.24 14.24% 1Y
-65.16 76.95% 3Y
-4.31 18.09% 5Y
+12.74 187.69% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.50 2.63%
ISIN
IL0011595993
Symbol
INMD
Sector

Key metrics

Market capitalization $1.65b
Enterprise Value $972.19m
P/E (TTM) P/E ratio 10.55
EV/FCF (TTM) EV/FCF 6.17
EV/Sales (TTM) EV/Sales 2.29
P/S ratio (TTM) P/S ratio 3.90
P/B ratio (TTM) P/B ratio 2.24
Revenue growth (TTM) Revenue growth -15.05%
Revenue (TTM) Revenue $423.75m
EBIT (operating result TTM) EBIT $135.91m
Free Cash Flow (TTM) Free Cash Flow $157.55m
Cash position $684.89m
EPS (TTM) EPS $1.85
P/E forward 11.31
P/S forward 4.02
EV/Sales forward 2.36
Short interest 8.77%
Show more

Is Inmode a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Inmode Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Inmode forecast:

3x Buy
43%
4x Hold
57%

Analyst Opinions

7 Analysts have issued a Inmode forecast:

Buy
43%
Hold
57%

Financial data from Inmode

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Oct '24
+/-
%
424 424
-
100%
- Direct Costs 78 78
-
18%
346 346
-
82%
- Selling and Administrative Expenses 195 195
-
46%
- Research and Development Expense 14 14
-
3%
137 137
-
32%
- Depreciation and Amortization 0.60 0.60
-
0%
EBIT (Operating Income) EBIT 136 136
-
32%
Net Profit 154 154
-
36%

In millions USD.

Don't miss a Thing! We will send you all news about Inmode directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Inmode Stock News

Neutral
PRNewsWire
20 days ago
YOKNEAM, Israel , Nov. 6, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in November and December: UBS Global Healthcare Conference Presenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Danielle Antalffy, Senior Equity Ana...
Negative
Seeking Alpha
21 days ago
Elevated interest rates continue to hurt InMode's revenue, especially as lease package interest rates haven't fallen yet. Still, future rate cuts could release pent-up demand. InMode continues to buy back shares at a low price, which will boost per-share results. InMode's manufacturing is done in Israel, presenting a risk, but the company has been managing this well despite the war.
Positive
Seeking Alpha
26 days ago
InMode's products are part of the medical aesthetics industry that is expected to grow at an 11% CAGR over the next five years. Despite a punishing macro environment of late that has seen its share price decline over 80% from its peak, InMode has remained profitable while continuing to innovate. The strong new and second-hand sales market for their platforms suggest their customers continue to ...
More Inmode News

Company Profile

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

Head office Israel
CEO Moshe Mizrahy
Employees 581
Founded 2008
Website www.inmodemd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today